CN209883191U - Shoe-pad for diabetes patient - Google Patents

Shoe-pad for diabetes patient Download PDF

Info

Publication number
CN209883191U
CN209883191U CN201821382027.1U CN201821382027U CN209883191U CN 209883191 U CN209883191 U CN 209883191U CN 201821382027 U CN201821382027 U CN 201821382027U CN 209883191 U CN209883191 U CN 209883191U
Authority
CN
China
Prior art keywords
insole
pad
sole
shoe
foot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201821382027.1U
Other languages
Chinese (zh)
Inventor
张辉
娄蒙龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Is Liked Because Of Ltd Co Of Diabetes Health Science Research Institute
Original Assignee
Henan Is Liked Because Of Ltd Co Of Diabetes Health Science Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Is Liked Because Of Ltd Co Of Diabetes Health Science Research Institute filed Critical Henan Is Liked Because Of Ltd Co Of Diabetes Health Science Research Institute
Priority to CN201821382027.1U priority Critical patent/CN209883191U/en
Application granted granted Critical
Publication of CN209883191U publication Critical patent/CN209883191U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)

Abstract

The utility model discloses a shoe-pad for diabetic relates to shoe-pad technical field, solves current shoe-pad for diabetic gas permeability and antibiotic property poor and easily make the problem of whole foot infection. The utility model discloses a shoe-pad body is located and is equipped with a preceding foot recess on the shoe-pad body of toe and preceding sole department, is located and is equipped with the back foot recess on the shoe-pad body of heel department, glue respectively in preceding foot recess and the back foot recess and glue have with preceding foot recess and back foot recess assorted preceding foot pad and back callus on the sole, preceding callus on the sole and back callus on the sole all include from the bottom up in proper order glue glutinous activated carbon layer, the cotton layer of bubble and the antibiotic insole face of setting, a plurality of air vents have been seted up on the cotton layer of bubble, air vent intercommunication antibiotic insole face and activated carbon layer. The utility model has the advantages of good air permeability and good antibacterial effect.

Description

Shoe-pad for diabetes patient
Technical Field
The utility model relates to an insole technical field, more specifically relate to an insole for diabetes patient.
Background
The diabetic foot is a general term for foot pain, deep skin ulcer, acromelic gangrene and other lesions caused by diabetes complex factors, and is one of chronic complications of diabetes and one of the main causes of disabled and dead diabetic patients, wherein the foot infection, ulcer and deep tissue damage related to lower limb distal nerve abnormality and peripheral vascular lesions of different degrees, the foot infection, ulcer and deep tissue damage related to the neuropathy and the loss of sensation and vitality due to ischemia are caused, and the foot with combined infection is called the diabetic foot. Diabetic patients are vulnerable to trauma because neuropathy often easily causes loss or reduction of foot strength, and mild trauma to diabetic patients can rapidly cause ulcers, infections and gangrene, so that amputation is finally forced, and the amputation rate is as high as 40%. Patients and physicians tend to pay more attention to diabetic foot ulcers because they can lead to the feared outcome of amputation, ignoring the small neurological lesions that are most common and responsible for the loss of foot function that can be prevented through education and early treatment of the patient.
The existing insoles for diabetics generally mainly have comfort and ventilation, but do not have antibacterial property or poor antibacterial property, once wounds appear on feet of diabetics, the existing insoles are easy to permeate into, and once the existing insoles permeate into the feet, the whole feet of the diabetics are easy to be infected.
SUMMERY OF THE UTILITY MODEL
The utility model aims to provide a: in order to solve the problem that the whole foot is infected easily because of poor air permeability and antibacterial property of the existing insole for the diabetes patient, the utility model provides an insole for the diabetes patient with good air permeability and good antibacterial effect.
The utility model discloses a realize above-mentioned purpose and specifically adopt following technical scheme:
the utility model provides a shoe-pad for diabetic patient, includes the shoe-pad body, is located to be equipped with a preceding foot recess on the shoe-pad body of toe and preceding sole department, is located to be equipped with the back foot recess on the shoe-pad body of heel department, glue respectively in preceding foot recess and the back foot recess and glue before having and stick preceding foot recess and back foot recess assorted callus on the sole, preceding callus on the sole and back callus on the sole all include from the bottom up in proper order glue glutinous activated carbon layer, the cotton layer of bubble and the antibiotic heelpiece face that sets up, a plurality of air vents have been seted up on the cotton layer of bubble, air vent intercommunication antibiotic heelpiece face and activated carbon layer. The utility model is provided with the front foot pad at the position of the toes and the front sole which are frequently contacted and rubbed with the shoes, and the rear foot pad at the position of the heel, when a diabetic wears the utility model, the toes, the front sole and the heel are contacted with the uppermost antibacterial insole, thereby playing the antibacterial role on the toes, the front sole and the heel; the foam layer has good elasticity, light weight and strong recovery performance, so that the contact comfort between the front sole and the heel and the insole is strong; because the air holes communicated with the antibacterial insole surface and the activated carbon layer are formed in the foam layer, water vapor or sweat on toes, the front sole and the heel is adsorbed by the activated carbon in the activated carbon layer, so that the feet are kept dry, and infection is avoided.
Preferably, the antibacterial insole surface is made of silver fibers, bamboo fibers and lycra fabric which are mixed and woven. The silver fiber in the antibacterial insole surface of the utility model has good antibacterial, mildew-proof and deodorizing functions through the labor-saving process of blocking bacteria; the bamboo fiber has the characteristics of good air permeability, instant water absorption, strong wear resistance and the like, and has the functions of natural antibiosis, bacteriostasis, mite removal, deodorization and ultraviolet resistance; the elasticity of lycra fabric is good, the comfort level is high, the utility model discloses mix silver fibre, bamboo fibre and lycra fabric and weave into antibiotic insole face and can further improve antibiotic, the moisture absorption and the comfort level of shoe-pad.
Preferably, the particle size of the activated carbon contained in the activated carbon layer is 0.1mm-0.15 mm. If the particle size of the activated carbon is too large, the patient feels uncomfortable by pressing the feet although the foam layer is arranged on the upper part of the activated carbon layer, and the wearing comfort can be improved by the small particle size of the activated carbon.
Preferably, the material of the foam layer is EVA. The EVA is an ethylene-vinyl acetate copolymer, has the advantages of good buffering, shock resistance, heat insulation, moisture resistance, chemical corrosion resistance and the like, is nontoxic and high in resilience, and increases the comfort level.
Preferably, the insole body comprises an insole base body and a surface material adhered to the insole base body through EVA foam glue.
Preferably, the peripheries of the front foot pad and the rear foot pad are level to the upper surface of the insole body, the curvature radius of a curve formed by the downward depression of the middle part of the front foot pad is 30-40mm, and the curvature radius of a curve formed by the upward protrusion of the middle part of the rear foot pad is 20-30 mm. The design is in accordance with human engineering, and the wearing comfort is enhanced.
The utility model has the advantages as follows:
1. when the utility model is worn by a diabetic, toes, a front sole and heels are contacted with the uppermost layer of antibacterial insole, and the toes, the front sole and the heels have antibacterial function; the foam layer has good elasticity, light weight and strong recovery performance, so that the contact comfort between the front sole and the heel and the insole is strong; because the air holes communicated with the antibacterial insole surface and the activated carbon layer are formed in the foam layer, water vapor or sweat on toes, the front sole and the heel is adsorbed by the activated carbon in the activated carbon layer, so that the feet are kept dry, and infection is avoided.
2. The antibacterial insole surface of the utility model is formed by mixing and weaving silver fiber, bamboo fiber and lycra fabric, and the silver fiber has good antibacterial and mildew-proof deodorizing functions through the labor-saving process of blocking bacteria; the bamboo fiber has the characteristics of good air permeability, instant water absorption, strong wear resistance and the like, and has the functions of natural antibiosis, bacteriostasis, mite removal, deodorization and ultraviolet resistance; the elasticity of lycra fabric is good, the comfort level is high, the utility model discloses mix silver fibre, bamboo fibre and lycra fabric and weave into antibiotic insole face and can further improve antibiotic, the moisture absorption and the comfort level of shoe-pad.
3. The particle diameter of the active carbon filled in the active carbon layer of the utility model is 0.1mm-0.15 mm. If the particle size of the activated carbon is too large, the patient feels uncomfortable by pressing the feet although the foam layer is arranged on the upper part of the activated carbon layer, and the wearing comfort can be improved by the small particle size of the activated carbon.
Drawings
Fig. 1 is a top view of the present invention;
FIG. 2 is a schematic structural view of the present invention;
FIG. 3 is a cross-sectional view of the forefoot pad;
fig. 4 is a cross-sectional view of the rear foot pad.
Reference numerals: 1-insole body, 2-forefoot groove, 3-forefoot pad, 4-rearfoot groove, 5-rearfoot pad, 6-vent hole, 7-antibacterial insole surface, 8-foam layer, 9-activated carbon layer, 10-insole base body and 11-plane material.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all, embodiments of the present invention. The components of embodiments of the present invention, as generally described and illustrated in the figures herein, may be arranged and designed in a wide variety of different configurations.
Thus, the following detailed description of the embodiments of the present invention, presented in the accompanying drawings, is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative efforts belong to the protection scope of the present invention.
It should be noted that: like reference numbers and letters refer to like items in the following figures, and thus, once an item is defined in one figure, it need not be further defined and explained in subsequent figures. Furthermore, the terms "first," "second," and the like are used merely to distinguish one description from another, and are not to be construed as indicating or implying relative importance.
In the description of the embodiments of the present invention, it should be noted that the terms "inside", "outside", "up", and the like indicate the directions or positional relationships based on the directions or positional relationships shown in the drawings, or the directions or positional relationships that the products of the present invention are conventionally placed when used, and are only for convenience of describing the present invention and simplifying the description, but do not indicate or imply that the device or element to which the term refers must have a specific direction, be constructed and operated in a specific direction, and thus, should not be construed as limiting the present invention.
Example 1
As shown in fig. 1 to 4, the embodiment provides an insole for diabetic, including insole body 1, be located and be equipped with a preceding foot recess 2 on the insole body 1 of toe and preceding sole department, be located and be equipped with back foot recess 4 on the insole body 1 of heel department, glue respectively in preceding foot recess 2 and the back foot recess 4 and glue and have preceding foot pad 3 and back callus on the sole 5 with preceding foot recess 2 and back foot recess 4 assorted, preceding callus on the sole 3 and back callus on the sole 5 all include from the bottom up and glue activated carbon layer 9, the cotton layer 8 of bubble and the antibiotic insole face 7 of gluing the setting in proper order, a plurality of air vents 6 have been seted up on the cotton layer 8 of bubble, air vent 6 intercommunication antibiotic insole face 7 and activated carbon layer 9. The utility model is provided with the front foot pad at the position of the toes and the front sole which are frequently contacted and rubbed with the shoes, and the rear foot pad at the position of the heel, when a diabetic wears the utility model, the toes, the front sole and the heel are contacted with the uppermost antibacterial insole, thereby playing the antibacterial role on the toes, the front sole and the heel; the foam layer has good elasticity, light weight and strong recovery performance, so that the contact comfort between the front sole and the heel and the insole is strong; because the air holes communicated with the antibacterial insole surface and the activated carbon layer are formed in the foam layer, water vapor or sweat on toes, the front sole and the heel is adsorbed by the activated carbon in the activated carbon layer, so that the feet are kept dry, and infection is avoided.
Example 2
As shown in fig. 1 to 4, the present embodiment is further improved on the basis of embodiment 1, and specifically, the material of the antibacterial insole surface 7 is formed by weaving silver fibers, bamboo fibers and lycra fabric in a mixed manner. The silver fiber in the antibacterial insole surface of the utility model has good antibacterial, mildew-proof and deodorizing functions through the labor-saving process of blocking bacteria; the bamboo fiber has the characteristics of good air permeability, instant water absorption, strong wear resistance and the like, and has the functions of natural antibiosis, bacteriostasis, mite removal, deodorization and ultraviolet resistance; the elasticity of lycra fabric is good, the comfort level is high, the utility model discloses mix silver fibre, bamboo fibre and lycra fabric and weave into antibiotic insole face and can further improve antibiotic, the moisture absorption and the comfort level of shoe-pad.
The particle size of the active carbon contained in the active carbon layer 9 is 0.1mm-0.15 mm. If the particle size of the activated carbon is too large, the patient feels uncomfortable by pressing the feet although the foam layer is arranged on the upper part of the activated carbon layer, and the wearing comfort can be improved by the small particle size of the activated carbon.
The material of the foam layer 8 is EVA. The EVA is an ethylene-vinyl acetate copolymer, has the advantages of good buffering, shock resistance, heat insulation, moisture resistance, chemical corrosion resistance and the like, is nontoxic and high in resilience, and increases the comfort level.
Example 3
As shown in fig. 1 to 4, this embodiment is further improved on the basis of embodiments 1 and 2, specifically, the insole body 1 includes an insole base 10 and a surface material 11 adhered to the insole base 10 by EVA foam glue.
The peripheries of the front foot pad 3 and the rear foot pad 5 are level to the upper surface of the insole body 1, the curvature radius of a curve formed by downward sinking of the middle part of the front foot pad 3 is 30-40mm, and the curvature radius of a curve formed by upward protruding of the middle part of the rear foot pad 5 is 20-30 mm. The design is in accordance with human engineering, and the wearing comfort is enhanced.

Claims (6)

1. An insole for a diabetic patient comprises an insole body (1) and is characterized in that: be equipped with a preceding foot recess (2) on shoe-pad body (1) that is located toe and preceding sole department, be equipped with back foot recess (4) on shoe-pad body (1) that is located heel department, glue respectively in preceding foot recess (2) and back foot recess (4) and glue before having with preceding foot recess (2) and back foot recess (4) assorted callus on the sole (3) and back callus on the sole (5), preceding callus on the sole (3) and back callus on the sole (5) all include from the bottom up glue in proper order and glue activated carbon layer (9), bubble cotton layer (8) and antibiotic insole face (7) that set up, a plurality of air vents (6) have been seted up on bubble cotton layer (8), air vent (6) intercommunication antibiotic insole face (7) and activated carbon layer (9).
2. The insole for diabetic patients according to claim 1, wherein: the antibacterial insole surface (7) is made of silver fibers, bamboo fibers and lycra fabric which are mixed and woven.
3. The insole for diabetic patients according to claim 1, wherein: the particle size of the active carbon contained in the active carbon layer (9) is 0.1mm-0.15 mm.
4. The insole for diabetic patients according to claim 1, wherein: the foam layer (8) is made of EVA.
5. The insole for diabetic patients according to claim 1, wherein: the insole body (1) comprises an insole base body (10) and a surface material (11) adhered to the insole base body (10) through EVA foam glue.
6. The insole for diabetic patients according to claim 1, wherein: the insole is characterized in that the peripheries of the front foot pad (3) and the rear foot pad (5) are level with the upper surface of the insole body (1), the curvature radius of a curve formed by downward sinking of the middle part of the front foot pad (3) is 30-40mm, and the curvature radius of a curve formed by upward protruding of the middle part of the rear foot pad (5) is 20-30 mm.
CN201821382027.1U 2018-08-22 2018-08-22 Shoe-pad for diabetes patient Expired - Fee Related CN209883191U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201821382027.1U CN209883191U (en) 2018-08-22 2018-08-22 Shoe-pad for diabetes patient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201821382027.1U CN209883191U (en) 2018-08-22 2018-08-22 Shoe-pad for diabetes patient

Publications (1)

Publication Number Publication Date
CN209883191U true CN209883191U (en) 2020-01-03

Family

ID=68989552

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201821382027.1U Expired - Fee Related CN209883191U (en) 2018-08-22 2018-08-22 Shoe-pad for diabetes patient

Country Status (1)

Country Link
CN (1) CN209883191U (en)

Similar Documents

Publication Publication Date Title
CN209883191U (en) Shoe-pad for diabetes patient
CN207136371U (en) It is capable of the multifunction shoe pads of alleviating foot fatigue
CN205409930U (en) Breathable insole
CN210158110U (en) Antibiotic function's motion shoe-pad
CN212520978U (en) Odor-resistant mulla shoes
CN211129891U (en) Children ventilation shoes
CN209677523U (en) A kind of correction massage insole and playshoes
CN219537606U (en) Antibacterial breathable graphene insole
CN213074715U (en) Rehabilitation insole for diabetic foot in endocrinology department
CN209643997U (en) One kind is breathed freely comfortable Multifunctional shoe
CN111959053A (en) Healthy comfortable shoe-pad
CN213939888U (en) Novel antibacterial and anti-skidding insole
CN212065869U (en) Sterilizing and deodorizing memory insole
CN215303396U (en) Breathable heel-of-woman shoe foot bed and heel-of-woman shoes
CN210076588U (en) Diabetic foot nursing socks
CN215397323U (en) Antibacterial breathable insole fabric
CN205512679U (en) Health care woman's shoe
CN212014694U (en) Novel shoe pad
CN216147349U (en) Light ventilative sports shoes
CN109757820A (en) A kind of anti-skidding, deodorization, damping aroma type health shoes
CN218682400U (en) Massage insole
CN212306983U (en) Shoes for diabetic foot patients
CN219353182U (en) Protective shoes for diabetic foot
CN2674903Y (en) Moisture guiding sweat absorbing insole
CN212164921U (en) Deodorant effectual cotton socks

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200103

Termination date: 20200822